PFE Pfizer Earnings and EPS analysis

EPS in 2025 (TTM): $1.39

Last Report Period Date: Mar 30, 2025

Based on the company's latest reports for March 2025, the current 12-month EPS is $1.39. Pfizer's earnings per share in 2024 was reported at $1.42, marking a rise from $0.38 in 2023. In the quarterly report ending on Mar 30, 2025, PFE's earnings per share amounted to $0.52.

Pfizer had an yealy earnings per share of $1.42, showing a rise of 273.7% from $0.38 recorded in 2023. The quarterly earnings per share for the period ending Mar 30, 2025, was $0.52, showing a 5.5% decline compared to the same quarter last year. The trailing twelve months EPS for PFE is $1.39 as of March 2025. Pfizer's full-year EPS for 2023 was $0.38, a 93.2% decline compared to the previous year.

Pfizer has recorded a decline in earnings per share of 5.5% in the past 12 months (YoY, quarterly). During the past three years, PFE registered an average yearly EPS growth of -28.7%. Pfizer had an average annual EPS growth of -13.2% in the last five years. Over the last decade, PFE had an average annual earnings per share growth of -0.1%.